Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Nu Skin Enterprises, Inc. (NYSE: NUS) closed at $10.24 in the last session, down -0.10% from day before closing price of $10.25. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 0.63 million shares were traded. NUS stock price reached its highest trading level at $10.51 during the session, while it also had its lowest trading level at $10.14.
Ratios:
We take a closer look at NUS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 2.09. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 31, 2023, Downgraded its rating to Hold and sets its target price to $39 from $43 previously.
BofA Securities Upgraded its Underperform to Neutral on October 02, 2020, whereas the target price for the stock was revised from $54 to $58.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 28 ’24 when LIPMAN ANDREW D sold 2,000 shares for $13.33 per share. The transaction valued at 26,660 led to the insider holds 23,225 shares of the business.
WOODBURY EDWINA D sold 1,693 shares of NUS for $20,350 on May 02 ’24. The Director now owns 18,095 shares after completing the transaction at $12.02 per share. On Apr 25 ’24, another insider, LIPMAN ANDREW D, who serves as the Director of the company, sold 2,000 shares for $12.34 each. As a result, the insider received 24,680 and left with 25,225 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUS now has a Market Capitalization of 508594176 and an Enterprise Value of 951349184. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at 0.499 whereas that against EBITDA is 4.848.
Stock Price History:
Over the past 52 weeks, NUS has reached a high of $26.66, while it has fallen to a 52-week low of $9.74. The 50-Day Moving Average of the stock is -11.59%, while the 200-Day Moving Average is calculated to be -30.44%.
Shares Statistics:
According to the various share statistics, NUS traded on average about 764.96K shares per day over the past 3-months and 565930 shares per day over the past 10 days. A total of 49.50M shares are outstanding, with a floating share count of 48.71M. Insiders hold about 1.93% of the company’s shares, while institutions hold 86.04% stake in the company. Shares short for NUS as of 1721001600 were 2812245 with a Short Ratio of 3.68, compared to 1718323200 on 2206973. Therefore, it implies a Short% of Shares Outstanding of 2812245 and a Short% of Float of 8.17.
Dividends & Splits
The forward annual dividend rate for NUS is 0.90, which was 1.23 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.120000005The stock’s 5-year Average Dividend Yield is 4.6.
Earnings Estimates
The firm’s stock currently is rated by 3.0 analysts. The consensus estimate for the next quarter is $0.42, with high estimates of $0.48 and low estimates of $0.38.
Analysts are recommending an EPS of between $1.12 and $1.08 for the fiscal current year, implying an average EPS of $1.1. EPS for the following year is $1.48, with 3.0 analysts recommending between $1.58 and $1.39.
Revenue Estimates
According to 3 analysts, the current quarter’s revenue is expected to be $431.87M. It ranges from a high estimate of $433.01M to a low estimate of $430M. As of the current estimate, Nu Skin Enterprises, Inc.’s year-ago sales were $509.28MFor the next quarter, 3 analysts are estimating revenue of $459.86M. There is a high estimate of $465.7M for the next quarter, whereas the lowest estimate is $455M.
A total of 3 analysts have provided revenue estimates for NUS’s current fiscal year. The highest revenue estimate was $1.78B, while the lowest revenue estimate was $1.77B, resulting in an average revenue estimate of $1.77B. In the same quarter a year ago, actual revenue was $1.97BBased on 3 analysts’ estimates, the company’s revenue will be $1.83B in the next fiscal year. The high estimate is $1.87B and the low estimate is $1.79B.
